|
Volumn 3, Issue 5, 2000, Pages 263-264
|
Is there a role for glyoxalase I inhibitors as antitumor drugs?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 HYDROXYACID;
ANTINEOPLASTIC AGENT;
BROMOBENZENE;
CASPASE;
CELL PROTEIN;
COMPLEMENTARY DNA;
DOXORUBICIN;
ETOPOSIDE;
GLUTATHIONE;
GLUTATHIONE DERIVATIVE;
GLUTATHIONE TRANSFERASE;
LACTIC ACID;
LACTOYLGLUTATHIONE LYASE;
LACTOYLGLUTATHIONE LYASE INHIBITOR;
MESSENGER RNA;
METHYLGLYOXAL;
NUCLEIC ACID;
PEPTIDE DERIVATIVE;
S (N 4 CHLOROPHENYL N HYDROXYCARBAMOYL)GLUTATHIONE DIETHYL ESTER;
S (N HYDROXYCARBAMOYL)GLUTATHIONE DERIVATIVE;
S 4 BROMOBENZYLGLUTATHIONE CYCLOPENTYL ESTER;
TLK 199;
UNCLASSIFIED DRUG;
AMINO ACID SUBSTITUTION;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
CANCER;
CANCER GROWTH;
CARCINOGENESIS;
CELL DIVISION;
CELL PROLIFERATION;
DNA RNA HYBRIDIZATION;
DRUG EFFICACY;
ENZYME ACTIVATION;
ENZYME INHIBITION;
HUMAN;
LEUKEMIA CELL;
PLEIOTROPY;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
SHORT SURVEY;
|
EID: 0033646495
PISSN: 13687646
EISSN: None
Source Type: Journal
DOI: 10.1054/drup.2000.0155 Document Type: Article |
Times cited : (6)
|
References (17)
|